Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second‐Generation Antipsychotics (SGA)‐Induced Metabolic Syndrome (MetS)
ABSTRACT Second‐generation antipsychotics (SGA) are widely used for treating psychiatric disorders; however, their use is associated with an increased risk of metabolic syndrome (MetS). To identify common genetic associations of SGA‐induced metabolic syndrome (SGA‐MetS), we conducted a genome‐wide a...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|